Wegovy

Wegovy is a prescription medication containing the active ingredient semaglutide. It is specifically indicated for chronic weight management in adults with obesity or overweight conditions. Wegovy works by mimicking the action of a hormone called GLP-1, which regulates appetite and food intake.

This injectable medication has been clinically studied and has demonstrated significant weight loss results when used in conjunction with a reduced-calorie diet and increased physical activity. Wegovy is administered as a once-weekly injection, making it convenient for those seeking effective weight loss solutions.

WEGOVY^® (semaglutide) injection 2.4 mg is an injectable prescription medicine that may help adults and children aged ≥12 years with obesity (BMI ≥30 for adults, BMI ≥ 95th percentile for age and sex for children), or some adults with excess weight (BMI ≥27) (overweight) who also have weight-related medical problems to help them lose weight and keep it off. Wegovy^® should be used with a reduced calorie meal plan and increased physical activity

• Wegovy^® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines
• It is not known if Wegovy^® is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products
• It is not known if Wegovy^® can be used safely in people with a history of pancreatitis
• It is not known if Wegovy^® is safe and effective for use in children under 12 years of age

As a reputable online pharmacy in the UK, My London Pharmacy is proud to offer Wegovy as part of our weight management treatments. When you buy Wegovy from us, your order will be reviewed by a UK registered pharmacist, ensuring personalized care and safety. Our aim is to provide Wegovy at competitive prices, making it accessible to those seeking effective weight loss solutions in the UK.

We understand the importance of cost considerations when it comes to weight management medications. At My London Pharmacy, we strive to offer Wegovy at competitive prices, ensuring affordability without compromising on quality. The cost of Wegovy may vary based on the treatment duration and dosage required. We recommend consulting with our healthcare professionals to determine the most suitable Wegovy treatment plan for you.

Wegovy^® (semaglutide) injection 2.4 mg is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in:

• adults with an initial body mass index (BMI) of ≥30 kg/m² (obesity) or ≥27 kg/m² (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia) 
• pediatric patients aged 12 years and older with an initial BMI at the 95^th percentile or greater standardized for age and sex (obesity)

Limitations of Use

• Wegovy^® contains semaglutide and should not be coadministered with other semaglutide-containing products or with any GLP-1 receptor agonist
• The safety and effectiveness of Wegovy^® in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established
• Wegovy^® has not been studied in patients with a history of pancreatitis

Impact of Weight Loss Injections on Contraception

Important notice for patients using weight loss medications and taking the pill or HRT

Many patients are now using weight loss medications such as Tirzepatide (Mounjaro) or Semaglutide (Ozempic, Wegovy, Rybelsus) — either for diabetes management or privately for weight loss.

These medications work partly by slowing how your stomach empties, which can affect how well other medicines (like the contraceptive pill or HRT tablets) are absorbed by your body.

If you take the contraceptive pill:

Tirzepatide (Mounjaro)

This medicine may reduce how well the pill works.

You should:

• Use a non-oral method (e.g. coil or implant), or
• Add a barrier method (like condoms) for 4 weeks after starting or increasing the dose.
• Use extra protection (like condoms) if you have vomiting or diarrhoea, and follow the missed pill rules (see your pill’s patient leaflet) if you vomit within 3 hours of taking the pill or have diarrhoea lasting more than 24 hours.

Semaglutide (Ozempic, Wegovy, Rybelsus) and others

These medicines do not appear to reduce the effectiveness of the pill.

However, side effects such as vomiting or diarrhoea can still reduce how well the pill is absorbed.

Use extra protection (like condoms) if these occur and follow the missed pill rules as above.

📎 Please see further information here: “Patient Information – GLP-1 Agonists and Contraception.”

If you’re taking Hormone Replacement Therapy (HRT):

This applies if your HRT includes progesterone tablets such as:

• Progesterone (Utrogestan)
• Norethisterone
• Medroxyprogesterone acetate

There is some concern that weight loss medications like Tirzepatide and Semaglutide may reduce how well these tablets are absorbed. This could cause irregular bleeding and may affect the protection of your womb lining, potentially increasing the risk of endometrial cancer.

Please contact your prescriber or pharmacy team to discuss your HRT or contraception options while using weight loss medication.

Cardiovascular Benefits

Wegovy has been shown to provide benefits beyond weight loss:

• In the SELECT trial (2023), Wegovy reduced the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) by 20% in adults with overweight or obesity and established heart disease.
• It can also improve blood pressure, cholesterol, and inflammatory markers, contributing to better overall heart health.

Average Weight Loss Results

Clinical studies show that:

• Participants using Wegovy 2.4 mg once weekly lost an average of 15% of their body weight over 68 weeks.
• Around one-third of users lost more than 20% of their starting weight when combined with a healthy diet and physical activity.
• Weight loss typically builds up gradually, with visible results after 8–12 weeks and maximum benefit over several months.
•